Key Events This Week
1 June: Valuation shifts from attractive to fair, P/E at 18.58
2 June: Technical momentum shifts from strongly bearish to mildly bearish
5 June: Week closes at ₹75.86, down 1.34%
Aug 06, 12:24 PM
BSE+NSE Vol: 23.59 k

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. This change comes despite recent share price softness and a challenging industry backdrop, prompting a closer examination of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical levels and peer benchmarks.
Read full news article
Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Anuh Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Anuh Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a 4.34% gain on 15 Jun 2026, the micro-cap pharmaceutical stock continues to face mixed signals from key momentum and trend indicators, underscoring the challenges investors face in navigating its near-term outlook.
Read full news article
1 June: Valuation shifts from attractive to fair, P/E at 18.58
2 June: Technical momentum shifts from strongly bearish to mildly bearish
5 June: Week closes at ₹75.86, down 1.34%

Anuh Pharma Ltd (Stock ID: 905552) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. Despite a micro-cap status and a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and technical parameters warrant close examination for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news articleAnuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2026 and to consider any other matter with the permission of the Chairman.
In terms of the provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached herewith Notice of the 66th Annual General Meeting of the Company to be held on Wednesday 12th August 2026 at 4:00 p.m through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligation and Disclosures Requirements) Regulations 2015 please find enclosed herewith the copy of the Annual Report of the Company for the Financial Year 2025-26 for your information and records.
07 Aug 2026
Anuh Pharma Ltd has declared 30% dividend, ex-date: 05 Aug 26
Anuh Pharma Ltd has announced 5:10 stock split, ex-date: 31 Jul 06
Anuh Pharma Ltd has announced 1:1 bonus issue, ex-date: 15 Jul 25
No Rights history available